全部所有文章
-
UBP Receives Nomination from Biologics Manufacturing Asia (BMA)
UBP Receives Nomination from Biologics Manufacturing Asia (BMA)UBP Receives Nomination from Biologics Manufacturing Asia (BMA)more -
United BioPharma invited to present UB-421 Phase II clinical trial results in late breaker session at CROI 2017
United BioPharma invited to present UB-421 Phase II clinical trial results in late breaker session at CROI 2017United BioPharma invited to present UB-421 Phase II clinical trial results in late breaker session at CROI 2017more -
聯生藥 榮獲亞洲生物製品製程大會提名：台灣最佳生物製程技術獎 & 年度最佳生物製藥經理人獎
聯生藥 榮獲亞洲生物製品製程大會提名：台灣最佳生物製程技術獎 & 年度最佳生物製藥經理人獎聯生藥 榮獲亞洲生物製品製程大會提名：台灣最佳生物製程技術獎 & 年度最佳生物製藥經理人獎more -
聯生藥UB-421臨床二期試驗結果獲選為2017 CROI LATE BREAKER報告
聯生藥UB-421臨床二期試驗結果獲選為2017 CROI LATE BREAKER報告聯生藥UB-421臨床二期試驗結果獲選為2017 CROI LATE BREAKER報告more -
Dr. YwanFeng Li has joined United BioPharma
Dr. YwanFeng Li has joined United BioPharmaDr. YwanFeng Li has joined United BioPharmamore -
United Biopharma Submitted completed anti-HIV therapeutic mAb UB-421 Phase II Clinical Trial Report, to TFDA for review
United Biopharma Submitted completed anti-HIV therapeutic mAb UB-421 Phase II Clinical Trial Report, to TFDA for reviewUnited Biopharma Submitted completed anti-HIV therapeutic mAb UB-421 Phase II Clinical Trial Report, to TFDA for reviewmore -
UBP announces UB-421 research data at Cold Spring Harbor Laboratory Conference on HIV/AIDS Research
UBP announces UB-421 research data at Cold Spring Harbor Laboratory Conference on HIV/AIDS ResearchUBP announces UB-421 research data at Cold Spring Harbor Laboratory Conference on HIV/AIDS Researchmore
